Condition: Cardiovascular Diseases · Obesity · PreDiabetes · Sponsor: Brooklyn Clinical Research
SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms. Site staff may collect vital signs, urine drug screens, blood draws, and urine pregnancy tests. A doctor will review medical history with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians and pharmacies to determine eligibility for clinical trials.
This description comes directly from the study's public registry record.
Ammara Mushtaq, MD · 929-203-5879 · amushtaq@brooklynclinicalresearch.com
Katherine Azer, MS · 929-332-7848 · kazer@brooklynclinicalresearch.com
Always discuss trial participation with your own doctor first.
| Brooklyn Clinical Research | Brooklyn, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06412536